Literature DB >> 26385164

Lifestyle Intervention for People With Severe Obesity and Serious Mental Illness.

John A Naslund1, Kelly A Aschbrenner2, Emily A Scherer3, Sarah I Pratt2, Rosemarie S Wolfe4, Stephen J Bartels5.   

Abstract

INTRODUCTION: People with serious mental illness experience elevated severe obesity rates, yet limited evidence documents whether lifestyle intervention participation can benefit these individuals. This study examined the impact of the In SHAPE lifestyle intervention on weight loss among participants with serious mental illness and severe obesity (BMI ≥40) compared with participants who are overweight (BMI 25 to <30) and have class I (BMI 30 to <35) or class II (BMI 35 to <40) obesity.
METHODS: Data were combined from three trials of the 12-month In SHAPE intervention for individuals with serious mental illness collected between 2007 and 2013 and analyzed in 2014. In SHAPE includes individual weekly meetings with a fitness trainer, a gym membership, and nutrition education. The primary outcome was weight loss. Secondary outcomes were fitness, blood pressure, lipids, and program adherence.
RESULTS: Participants (N=192) were diagnosed with schizophrenia spectrum (53.1%) or mood (46.9%) disorders. At 12 months, the overall sample showed significant weight loss, but differences among BMI groups were not significant (severe obesity, 2.57% [7.98%]; class II, 2.26% [8.69%]; class I, 1.05% [6.86%]; overweight, 0.83% [7.62%]). One third of participants with severe obesity achieved ≥5% weight loss, which was comparable across groups. More participants with severe obesity achieved ≥10% weight loss (20%) than overweight (2.9%, p=0.001) and class I (5.9%, p<0.001), but not class II (17.8%, p=0.974), obesity groups.
CONCLUSIONS: People with severe obesity and serious mental illness benefit similarly to those in lower BMI groups from lifestyle intervention participation.
Copyright © 2016 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26385164      PMCID: PMC4718763          DOI: 10.1016/j.amepre.2015.07.012

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  30 in total

1.  The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

Authors: 
Journal:  Diabetes Care       Date:  2000-11       Impact factor: 19.112

Review 2.  Antipsychotic-induced weight gain: a comprehensive research synthesis.

Authors:  D B Allison; J L Mentore; M Heo; L P Chandler; J C Cappelleri; M C Infante; P J Weiden
Journal:  Am J Psychiatry       Date:  1999-11       Impact factor: 18.112

Review 3.  The beneficial effects of modest weight loss on cardiovascular risk factors.

Authors:  L F Van Gaal; M A Wauters; I H De Leeuw
Journal:  Int J Obes Relat Metab Disord       Date:  1997-03

4.  Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia.

Authors:  Martin Strassnig; Jaspreet S Brar; Rohan Ganguli
Journal:  Schizophr Res       Date:  2005-06-15       Impact factor: 4.939

5.  Body mass index and the prevalence of hypertension and dyslipidemia.

Authors:  C D Brown; M Higgins; K A Donato; F C Rohde; R Garrison; E Obarzanek; N D Ernst; M Horan
Journal:  Obes Res       Date:  2000-12

6.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield
Journal:  Arch Intern Med       Date:  2003-02-24

Review 7.  Atypical antipsychotics and weight gain--a systematic review.

Authors:  D M Taylor; R McAskill
Journal:  Acta Psychiatr Scand       Date:  2000-06       Impact factor: 6.392

8.  Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness.

Authors:  Gail L Daumit; Jeanne M Clark; Donald M Steinwachs; Camelia M Graham; Anthony Lehman; Daniel E Ford
Journal:  J Nerv Ment Dis       Date:  2003-12       Impact factor: 2.254

Review 9.  Effect of degree of weight loss on health benefits.

Authors:  G Blackburn
Journal:  Obes Res       Date:  1995-09

10.  Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.

Authors:  Craig W Colton; Ronald W Manderscheid
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830

View more
  10 in total

1.  Effects of a behavioural weight loss intervention in people with serious mental illness: Subgroup analyses from the ACHIEVE trial.

Authors:  Eleanore Alexander; Emma E McGinty; Nae-Yuh Wang; Arlene Dalcin; Gerald J Jerome; Edgar R Miller; Faith Dickerson; Jeanne Charleston; Deborah R Young; Joseph V Gennusa; Stacy Goldsholl; Courtney Cook; Lawrence J Appel; Gail L Daumit
Journal:  Obes Res Clin Pract       Date:  2019-03-07       Impact factor: 2.288

2.  Psychological interventions for psychosis in adolescents.

Authors:  Soumitra S Datta; Rhea Daruvala; Ajit Kumar
Journal:  Cochrane Database Syst Rev       Date:  2020-07-03

3.  Use of a Wearable Activity Device in Rural Older Obese Adults: A Pilot Study.

Authors:  John A Batsis; John A Naslund; Lydia E Gill; Rebecca K Masutani; Nayan Agarwal; Stephen J Bartels
Journal:  Gerontol Geriatr Med       Date:  2016-11-21

4.  The Validity and Reliability Characteristics of the M-BACK Questionnaire to Assess the Barriers, Attitudes, Confidence, and Knowledge of Mental Health Staff Regarding Metabolic Health of Mental Health Service Users.

Authors:  Andrew Watkins; Simon Rosenbaum; Philip B Ward; Joanna Patching; Elizabeth Denney-Wilson; Jane Stein-Parbury
Journal:  Front Public Health       Date:  2017-12-11

5.  Impact of community lifestyle intervention on anthropometric parameters and body composition among overweight and obese women: findings from the MyBFF@home study.

Authors:  Nor Azian Mohd Zaki; Geeta Appannah; Noor Safiza Mohamad Nor; Azahadi Omar; Mansor Fazliana; Rashidah Ambak; Siti Shafiatun Mohsin; Tahir Aris
Journal:  BMC Womens Health       Date:  2018-07-19       Impact factor: 2.809

6.  Multimodal lifestyle intervention using a web-based tool to improve cardiometabolic health in patients with serious mental illness: results of a cluster randomized controlled trial (LION).

Authors:  Anne Looijmans; Frederike Jörg; Richard Bruggeman; Robert A Schoevers; Eva Corpeleijn
Journal:  BMC Psychiatry       Date:  2019-11-05       Impact factor: 3.630

7.  Prevalence of Overweight and Obesity in People With Severe Mental Illness: Systematic Review and Meta-Analysis.

Authors:  Medhia Afzal; Najma Siddiqi; Bilal Ahmad; Nida Afsheen; Faiza Aslam; Ayaz Ali; Rubab Ayesha; Maria Bryant; Richard Holt; Humaira Khalid; Kousar Ishaq; Kamrun Nahar Koly; Sukanya Rajan; Jobaida Saba; Nilesh Tirbhowan; Gerardo A Zavala
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-25       Impact factor: 5.555

8.  The psychological journey of weight gain in psychosis.

Authors:  Felicity Waite; Amy Langman; Sophie Mulhall; Margaret Glogowska; Jamie Hartmann-Boyce; Paul Aveyard; Belinda Lennox; Thomas Kabir; Daniel Freeman
Journal:  Psychol Psychother       Date:  2022-02-08       Impact factor: 3.966

9.  Adaptation and validation of a scale of self-efficacy and social support for physical activity in Spanish patients with severe mental disorders.

Authors:  David Perez-Cruzado; Elisa Vera-Garcia; Fermin Mayoral-Cleries; Juan Vicente Luciano; Antonio Cuesta-Vargas
Journal:  Brain Behav       Date:  2019-12-26       Impact factor: 2.708

10.  Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile.

Authors:  Renato de Filippis; Raffaele Gaetano; Georgios Schoretsanitis; Giuseppe Verde; Cesare Anthony Oliveti; John M Kane; Cristina Segura-Garcia; Pasquale De Fazio
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-01       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.